Lexaria Bioscience (LEXX) Net Margin Growth (1y) (2018 - 2026)
Lexaria Bioscience (LEXX) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4,168.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 673.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2,208.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -1,652.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,636.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -392.00 |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 544,828.00 |
| Aug 31, 2025 | -106,732.00 |
| May 31, 2025 | 4,105.00 |
| Feb 28, 2025 | 113,793.00 |
| Nov 30, 2024 | 67,476.00 |
| Aug 31, 2024 | -128,453.00 |
| May 31, 2024 | -94,567.00 |
| Feb 29, 2024 | -607,809.00 |
| Nov 30, 2023 | 258,988.00 |
| Aug 31, 2023 | 522,384.00 |
| May 31, 2023 | 547,821.00 |
| Feb 28, 2023 | 184,009.00 |
| Nov 30, 2022 | 1.26 Mn |
| Aug 31, 2022 | 247,747.00 |
| May 31, 2022 | -113,660.00 |
| Feb 28, 2022 | 486,227.00 |
| Nov 30, 2021 | -1.41 Mn |
| Aug 31, 2021 | -268,041.00 |
| May 31, 2021 | 248,460.00 |
| Feb 28, 2021 | 232,048.00 |